SEC FORM 4
$1,327,130.18
BeOne Medicines Ltd. (ONC)
Sale of 3,680 shares at $360.6332 per share.
Reporting Person OYLER JOHN · Officer Title Chief Executive Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001042047-26-000019 · filed 2026-08-12 · View filing →